GeneDx Holdings Corp. Accounts Receivable
GeneDx Holdings Corp. (WGS) had Accounts Receivable of $83.61 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-03
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $83.61M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $76.93M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $74.37M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $60.94M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $83.61M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $76.93M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $74.37M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $60.94M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $48.03M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $45.98M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $37.63M 10-K · filed 2026-02-23 | $37.43M 10-Q · filed 2025-04-30 |
| 2023-03-31 | $32.91M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $42.63M 10-Q · filed 2023-05-09 | |
| 2022-09-30 | $42.67M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $45.80M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $37.64M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $26.51M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $21.26M 10-K · filed 2022-03-14 | |
| 2021-06-30 | $24.57M 10-K · filed 2022-03-14 | |
| 2021-03-31 | $33.34M 10-K · filed 2022-03-14 | |
| 2020-12-31 | $32.04M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |